Incannex Healthcare Inc. (IXHL)Healthcare | Drug Manufacturers - Specialty & Generic | Sydney, Australia | NasdaqCM
3.65 USD
+0.04
(1.108%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 3.59 -0.06 (-0.059%) ⇩ (April 17, 2026, 7:48 p.m. EDT) Short-term: ★☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 4 p.m. EDT
IXHL exhibits a highly volatile price pattern with a significant drop from its 52-week high of $49.8 to its current price of $3.12. The recent price history shows erratic fluctuations, with a notable decline in the last few weeks. The stock's high beta of 2.726 indicates it is significantly more volatile than the market, which makes it a risky short-term investment. The recent news about a reverse stock split and short interest growth may have contributed to the price instability. Additionally, the negative forward and trailing earnings per share suggest poor financial performance, which could be a red flag for long-term investors. With no dividend history, the stock is not attractive to income-focused investors. The forecasting model's negative predicted direction indicates a potential further decline in the short term, which makes it a poor candidate for short-term trading. Overall, the stock appears to be a high-risk investment with no clear momentum or yield potential. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.742435 |
| AutoETS | 0.758617 |
| AutoTheta | 0.761179 |
| MSTL | 0.769635 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 41% |
| H-stat | 36.22 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.068 |
| Excess Kurtosis | -1.68 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 0.222 |
| Market Cap | 51,003,876 |
| Forward P/E | -1.86 |
| Beta | 2.73 |
| Previous Name | Incannex Healthcare Limited |
| Website | https://www.incannex.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.79378533 |
| Address1 | 8 Century Circuit |
| Address2 | Suite 105 Norwest |
| All Time High | 11,528.4 |
| All Time Low | 2.4 |
| Ask | 3.67 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 497,820 |
| Average Daily Volume3 Month | 496,815 |
| Average Volume | 496,815 |
| Average Volume10Days | 497,820 |
| Beta | 2.726 |
| Bid | 3.61 |
| Bid Size | 1 |
| Book Value | 6.13 |
| City | Sydney |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Australia |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 3.65 |
| Current Ratio | 48.273 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 3.8081 |
| Day Low | 3.58 |
| Debt To Equity | 0.222 |
| Display Name | Incannex Healthcare |
| Earnings Timestamp End | 1,747,310,403 |
| Earnings Timestamp Start | 1,747,310,403 |
| Ebitda | -25,382,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 0.99 |
| Enterprise Value | -25,140,264 |
| Eps Forward | -1.96 |
| Eps Trailing Twelve Months | -22.2 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 4.7368 |
| Fifty Day Average Change | -1.0868001 |
| Fifty Day Average Change Percent | -0.2294376 |
| Fifty Two Week Change Percent | -79.37853 |
| Fifty Two Week High | 49.8 |
| Fifty Two Week High Change | -46.149998 |
| Fifty Two Week High Change Percent | -0.9267068 |
| Fifty Two Week Low | 2.4 |
| Fifty Two Week Low Change | 1.25 |
| Fifty Two Week Low Change Percent | 0.5208333 |
| Fifty Two Week Range | 2.4 - 49.8 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,646,231,400,000 |
| Float Shares | 10,689,442 |
| Forward Eps | -1.96 |
| Forward P E | -1.862245 |
| Free Cashflow | -9,415,000 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 12 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Gross Profits | 0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.10564 |
| Held Percent Institutions | 0.02892 |
| Implied Shares Outstanding | 13,973,664 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Industry Disp | Drug Manufacturers - Specialty & Generic |
| Industry Key | drug-manufacturers-specialty-generic |
| Ipo Expected Date | 2,022-02-25 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,751,241,600 |
| Last Split Date | 1,772,150,400 |
| Last Split Factor | 1:30 |
| Long Business Summary | Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that is in Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development for patients with generalized anxiety disorder. It is also developing IHL-675A, an oral fixed dose combination drug containing synthetic cannabidiol and hydroxychloroquine sulphate to treat rheumatoid arthritis, as well as lung inflammation, acute respiratory disease, chronic obstructive pulmonary disease, asthma, bronchitis, inflammatory bowel disease, colitis, and Crohn's disease. Incannex Healthcare Inc. is headquartered in Sydney, Australia. |
| Long Name | Incannex Healthcare Inc. |
| Market | us_market |
| Market Cap | 51,003,876 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_325166139 |
| Most Recent Quarter | 1,767,139,200 |
| Name Change Date | 2,026-04-18 |
| Net Income To Common | -48,500,000 |
| Next Fiscal Year End | 1,782,777,600 |
| Non Diluted Market Cap | 51,003,869 |
| Open | 3.75 |
| Operating Cashflow | -18,426,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 61 4 0984 0786 |
| Post Market Change | -0.05920005 |
| Post Market Change Percent | -1.621919 |
| Post Market Price | 3.5908 |
| Post Market Time | 1,776,469,737 |
| Prev Name | Incannex Healthcare Limited |
| Previous Close | 3.61 |
| Price Hint | 4 |
| Price To Book | 0.5954323 |
| Price To Sales Trailing12 Months | Infinity |
| Profit Margins | 0.0 |
| Quick Ratio | 47.963 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0400002 |
| Regular Market Change Percent | 1.10804 |
| Regular Market Day High | 3.8081 |
| Regular Market Day Low | 3.58 |
| Regular Market Day Range | 3.58 - 3.8081 |
| Regular Market Open | 3.75 |
| Regular Market Previous Close | 3.61 |
| Regular Market Price | 3.65 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 503,550 |
| Return On Assets | -0.36958 |
| Return On Equity | -1.30427 |
| Revenue Per Share | 0.0 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 13,973,663 |
| Shares Percent Shares Out | 0.0583 |
| Shares Short | 814,576 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 842,808 |
| Short Name | Incannex Healthcare Inc. |
| Short Percent Of Float | 0.0589 |
| Short Ratio | 1.09 |
| Source Interval | 15 |
| State | NSW |
| Symbol | IXHL |
| Total Cash | 68,900,000 |
| Total Cash Per Share | 5.768 |
| Total Debt | 163,000 |
| Total Revenue | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -22.2 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 11.2699 |
| Two Hundred Day Average Change | -7.6199 |
| Two Hundred Day Average Change Percent | -0.67612845 |
| Type Disp | Equity |
| Volume | 503,550 |
| Website | https://www.incannex.com |
| Zip | 2,153 |